179 related articles for article (PubMed ID: 28548004)
1. Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro.
Redondo J; Sarkar P; Kemp K; Virgo PF; Pawade J; Norton A; Emery DC; Guttridge MG; Marks DI; Wilkins A; Scolding NJ; Rice CM
Mult Scler; 2018 Jun; 24(7):919-931. PubMed ID: 28548004
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of Mesenchymal Stromal Cell Antioxidant Responses in Progressive Multiple Sclerosis.
Redondo J; Sarkar P; Kemp K; Heesom KJ; Wilkins A; Scolding NJ; Rice CM
Stem Cells Transl Med; 2018 Oct; 7(10):748-758. PubMed ID: 30063300
[TBL] [Abstract][Full Text] [Related]
3. Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis.
Sarkar P; Redondo J; Kemp K; Ginty M; Wilkins A; Scolding NJ; Rice CM
Cytotherapy; 2018 Jan; 20(1):21-28. PubMed ID: 28917625
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts.
de Oliveira GL; de Lima KW; Colombini AM; Pinheiro DG; Panepucci RA; Palma PV; Brum DG; Covas DT; Simões BP; de Oliveira MC; Donadi EA; Malmegrim KC
Cell Transplant; 2015; 24(2):151-65. PubMed ID: 24256874
[TBL] [Abstract][Full Text] [Related]
5. Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.
Le Y; Fraineau S; Chandran P; Sabloff M; Brand M; Lavoie JR; Gagne R; Rosu-Myles M; Yauk CL; Richardson RB; Allan DS
Stem Cell Rev Rep; 2016 Apr; 12(2):235-44. PubMed ID: 26649729
[TBL] [Abstract][Full Text] [Related]
6. Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis.
Harris VK; Faroqui R; Vyshkina T; Sadiq SA
Stem Cells Transl Med; 2012 Jul; 1(7):536-47. PubMed ID: 23197858
[TBL] [Abstract][Full Text] [Related]
7. Quantifying Senescence-Associated Phenotypes in Primary Multipotent Mesenchymal Stromal Cell Cultures.
Nadeau S; Cheng A; Colmegna I; Rodier F
Methods Mol Biol; 2019; 2045():93-105. PubMed ID: 31020633
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of bone marrow-derived mesenchymal stem cell quality from patients with congenital pseudoarthrosis of the tibia.
Dilogo IH; Mujadid F; Nurhayati RW; Kurniawan A
J Orthop Surg Res; 2018 Oct; 13(1):266. PubMed ID: 30352605
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
10. In vitro biosafety profile evaluation of multipotent mesenchymal stem cells derived from the bone marrow of sarcoma patients.
Lucarelli E; Bellotti C; Mantelli M; Avanzini MA; Maccario R; Novara F; Arrigo G; Zuffardi O; Zuntini M; Pandolfi M; Sangiorgi L; Lisini D; Donati D; Duchi S
J Transl Med; 2014 Apr; 12():95. PubMed ID: 24716831
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potential.
Klinkhammer BM; Kramann R; Mallau M; Makowska A; van Roeyen CR; Rong S; Buecher EB; Boor P; Kovacova K; Zok S; Denecke B; Stuettgen E; Otten S; Floege J; Kunter U
PLoS One; 2014; 9(3):e92115. PubMed ID: 24667162
[TBL] [Abstract][Full Text] [Related]
12. Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis.
Harris VK; Vyshkina T; Sadiq SA
Cytotherapy; 2016 Dec; 18(12):1476-1482. PubMed ID: 27727015
[TBL] [Abstract][Full Text] [Related]
13. Effects of high glucose conditions on the expansion and differentiation capabilities of mesenchymal stromal cells derived from rat endosteal niche.
Al-Qarakhli AMA; Yusop N; Waddington RJ; Moseley R
BMC Mol Cell Biol; 2019 Nov; 20(1):51. PubMed ID: 31752674
[TBL] [Abstract][Full Text] [Related]
14. Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis.
Mallam E; Kemp K; Wilkins A; Rice C; Scolding N
Mult Scler; 2010 Aug; 16(8):909-18. PubMed ID: 20542920
[TBL] [Abstract][Full Text] [Related]
15. An early-senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program.
Gnani D; Crippa S; Della Volpe L; Rossella V; Conti A; Lettera E; Rivis S; Ometti M; Fraschini G; Bernardo ME; Di Micco R
Aging Cell; 2019 Jun; 18(3):e12933. PubMed ID: 30828977
[TBL] [Abstract][Full Text] [Related]
16. Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis.
Cárdenes N; Álvarez D; Sellarés J; Peng Y; Corey C; Wecht S; Nouraie SM; Shanker S; Sembrat J; Bueno M; Shiva S; Mora AL; Rojas M
Stem Cell Res Ther; 2018 Sep; 9(1):257. PubMed ID: 30257725
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of mitochondrial fumarate hydratase in progressive multiple sclerosis contributes to impaired in vitro mesenchymal stromal cell-mediated neuroprotection.
Sarkar P; Redondo J; Hares K; Bailey S; Georgievskaya A; Heesom K; Kemp KC; Scolding NJ; Rice CM
Mult Scler; 2022 Jul; 28(8):1179-1188. PubMed ID: 34841955
[TBL] [Abstract][Full Text] [Related]
18. Skeletal-muscle-derived mesenchymal stem/stromal cells from patients with osteoarthritis show superior biological properties compared to bone-derived cells.
Čamernik K; Mihelič A; Mihalič R; Marolt Presen D; Janež A; Trebše R; Marc J; Zupan J
Stem Cell Res; 2019 Jul; 38():101465. PubMed ID: 31132579
[TBL] [Abstract][Full Text] [Related]
19. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
[TBL] [Abstract][Full Text] [Related]
20. [Bone healing capacity in patients undergoing total hip arthroplasty].
Kučera T; Soukup T; Krs O; Urban K; Sponer P
Acta Chir Orthop Traumatol Cech; 2012; 79(1):52-8. PubMed ID: 22405550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
